Is Emgality a Triptan or a Preventive Medication?

Emgality is not a triptan. It belongs to a completely different drug class called CGRP antagonists (calcitonin gene-related peptide antagonists). While both Emgality and triptans are used for migraine, they work through different biological mechanisms, are taken on different schedules, and serve different purposes in migraine management.

How Emgality Works

Emgality (galcanezumab) is a monoclonal antibody, which is a lab-made protein designed to target one specific substance in your body. In this case, it binds to a molecule called CGRP and blocks it from activating its receptor. CGRP plays a major role in triggering migraine attacks: it causes blood vessels around the brain to dilate and drives the inflammatory signaling that produces migraine pain. By neutralizing CGRP before it can do its job, Emgality works as a preventive treatment, reducing the number of migraine days you experience each month.

Emgality is FDA-approved for two conditions: preventive treatment of migraine in adults and treatment of episodic cluster headaches.

How Triptans Work Differently

Triptans (sumatriptan, rizatriptan, and others) are acute migraine treatments, meaning you take them during an attack to stop it. They work by activating serotonin receptors in the brain, which narrows dilated blood vessels and reduces the release of inflammatory compounds, including CGRP itself. The effect is fast but temporary, which is why triptans are taken as needed rather than on a schedule.

The core distinction: triptans stop a migraine that’s already happening. Emgality prevents migraines from starting in the first place. They target overlapping biology but from opposite directions and on completely different timelines.

Prevention vs. Acute Treatment

Emgality is given as a self-administered injection, not a pill you take during an attack. For migraine prevention, the typical approach is a loading dose of 240 mg (two injections of 120 mg) the first time, followed by one 120 mg injection per month. For episodic cluster headaches, the dose is 300 mg (three injections of 100 mg) at the start of a cluster period, then monthly until the cluster period ends. You can inject in the abdomen, thigh, back of the upper arm, or buttocks.

Triptans, by contrast, come as pills, nasal sprays, or injections taken at the onset of a migraine. You might use a triptan several times a month, but each dose is a one-time response to a specific attack.

How Effective Emgality Is at Reducing Migraines

Clinical trials give a clear picture of what to expect. In two studies involving 1,773 people with episodic migraines (averaging about nine migraine days per month), roughly 60% of those on Emgality saw their monthly migraine days cut in half after six months. That compared to 37% of people on placebo. In a separate study of 1,113 people with chronic migraines (averaging 19 migraine days per month), 28% on Emgality achieved at least a 50% reduction after three months, compared to 13% on placebo.

These numbers highlight something important: Emgality doesn’t eliminate migraines entirely for most people. It reduces their frequency, often significantly, but many patients still experience breakthrough attacks that need acute treatment.

Can You Take Both Together?

Yes. Because Emgality and triptans work through different mechanisms and serve different roles, they are commonly prescribed together. Emgality handles prevention on a monthly schedule while a triptan like sumatriptan stays in your toolkit for any migraines that break through. There are no known dangerous interactions between the two, and many people with moderate to severe migraine use both as part of a comprehensive treatment plan.

This combination reflects the broader shift in migraine care over the past several years. Before CGRP-targeting drugs like Emgality existed, preventive options were largely repurposed from other conditions: blood pressure medications, antidepressants, and anti-seizure drugs. Emgality was the first class of medication designed specifically to prevent migraines by targeting the underlying biology, which is why it can work alongside older acute treatments like triptans without overlap or conflict.